( 母液浓度为 40 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们客服联系。| 中文名称: | Mycro 3 一键复制产品信息 | ||||
|---|---|---|---|---|---|
| 英文名称: | Mycro 3 | ||||
| CAS No: | 944547-46-0 | 分子式: | C24H17ClF2N6O4 | 分子量: | 526.88 |
| CAS No: | 944547-46-0 | ||||
| 分子式: | C24H17ClF2N6O4 | ||||
| 分子量: | 526.88 | ||||
基本信息
|
产品编号:M10814 |
|||||
|
产品名称:Mycro 3 |
|||||
|
CAS: |
944547-46-0 |
储存条件 |
粉末 |
-20℃ |
四年 |
|
|
|
||||
|
分子式: |
溶于液体 |
-80℃ |
六个月 |
||
|
分子量 |
526.88 |
-20℃ |
一个月 |
||
|
化学名: |
|
||||
|
Solubility (25°C) |
体外 |
DMSO |
100mg/mL (189.79mM) |
||
|
Ethanol |
Insoluble |
||||
|
Water |
Insoluble |
||||
|
体内(现配现用) |
|
|
|||
|
<1mg/ml表示微溶或不溶。 |
|||||
|
普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 |
|||||
|
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
|||||
制备储备液
|
浓度
溶液体积 质量 |
1mg |
5mg |
10mg |
|
1mM |
1.8980mL |
9.4898mL |
18.9797mL |
|
5mM |
0.3796mL |
1.8980mL |
3.7959mL |
|
10mM |
0.1898mL |
0.9490mL |
1.8980mL |
|
50mM |
0.0380mL |
0.1898mL |
0.3796mL |
生物活性
|
产品描述 |
一种有效的选择 Myc-Max 二聚化抑制剂。Mycro 3 可用于胰腺癌的研究。 |
|
|
靶点/IC50 |
Myc-MAX dimerization |
|
|
体外研究 |
Mycro 3 is a potent and selective c-Myc inhibitor in whole cell assays, with weak inhibitory activity against Activator protein 1 (AP-1). Mycro 3 has a superior specificity profile to its predecessors.Mycro 3 inhibits the interaction between c-Myc and Max.Mycro 3 has high selectivity and inhibits c-Myc/Max dimerization and conjugation with DNA. Mycro 3 exhibits an excellent specificity with IC50s of 0.25 and 9.0 µM for cells with intact Myc alleles and Myc-null cells,respectively. |
|
|
体内研究 |
Mycro 3 (100mg/kg; oral administration; daily for two months) induces marked shrinkage of pancreatic ductal adenocarcinoma (PDA), increases cancer cell apoptosis, and reduces cell proliferation. Tumor growth is also drastically attenuated in Mycro 3-treated NOD/SCID mice carrying orthotopic or heterotopic xenografts of human pancreatic cancer cells. |
|
|
Animal Model: |
Moribund Pdx1-cre/KRAS* mice bearing pancreatic ductal adenocarcinoma (PDA) |
|
|
Dosage: |
100mg/kg |
|
|
Administration: |
Oral administration; daily for two months |
|
|
Result: |
Increased survival time. Mycro 3 administration was discontinued after two months, the mouse survived for an additional month. |
|
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
摩尔浓度计算公式
用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积
稀释公式
稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )
母液,添加 300 μLPEG300
混匀澄清,再加 50μLTween80, 混匀澄清,再加 600μLSaline/PBS/ddH2O
混匀澄清方案所需的各种助溶剂如: DMSO , PEG300 / PEG400 , Tween 80 , SBE-β-CD , 玉米油 等, 均可点击跳转或在网站搜索购买。
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
.png)
